PANCREATIC INSUFFICIENCY AND PULMONARY-DISEASE IN GERMAN AND SLAVIC CYSTIC-FIBROSIS PATIENTS WITH THE R347P MUTATION

被引:11
|
作者
VARON, R
STUHRMANN, M
MACEK, M
KUFARDJIEVA, A
ANGELICHEVA, D
MAGDORF, K
JORDANOVA, A
SAVOV, A
WAHN, U
MACEK, M
LALOV, V
IVANOVA, T
ELLEMUNTER, H
VAVROVA, V
FERAK, V
KAYSEROVA, H
REIS, A
KALAYDJIEVA, L
机构
[1] FREE UNIV BERLIN, INST HUMAN GENET, D-14059 BERLIN, GERMANY
[2] MHH, INST HUMAN GENET, D-30625 HANNOVER, GERMANY
[3] JOHNS HOPKINS MED INST, CTR MED GENET, BALTIMORE, MD 21287 USA
[4] UNIV SOFIA, CHILDRENS HOSP, BU-1126 SOFIA, BULGARIA
[5] UNIV SOFIA, OBSTET & GYNAECOL HOSP, MOLEC PATHOL LAB, BU-1431 SOFIA, BULGARIA
[6] FREE UNIV BERLIN, CHILDRENS HOSP, D-14059 BERLIN, GERMANY
[7] UNIV INNSBRUCK, CHILDRENS HOSP, DEPT CYST FIBROSIS, A-6020 INNSBRUCK, AUSTRIA
[8] CHARLES UNIV, FN MOTOL, DEPT MED GENET 2, PRAGUE 5, CZECH REPUBLIC
[9] CHARLES UNIV, FN MOTOL, PEDIAT CLIN, PRAGUE 5, CZECH REPUBLIC
[10] SLOVAK ACAD SCI, INST MOLEC PHYSIOL & GENET, BRATISLAVA 83334, SLOVAKIA
[11] DETER HOSP, BRATISLAVA, SLOVAKIA
[12] BURGAS REG HOSP, GENET COUNSELLING UNIT, BU-5000 BURGAS, BULGARIA
关键词
PANCREATIC INSUFFICIENCY; PULMONARY DISEASE; CYSTIC FIBROSIS; R347P MUTATION;
D O I
10.1002/humu.1380060304
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cystic fibrosis (CF) is caused by mutations in the gene for the cystic fibrosis transmembrane conductance regulator (CFTR) that codes for a cAMP-regulated chloride channel, The R347P is a missense mutation located within the first membrane spanning domain (MSD1) of the CFTR protein. This mutation occurs with an overall worldwide frequency of about 0.2%. The patients, originally described with this mutation were compound heterozgotes with the Delta F508 mutation and had a very mild course of CF, suggesting that R347P, similar to other missense mutations affecting the MSD1 domain, causes a mild phenotype. We report here a group of 19 CF patients with the R347P mutation of German, Bulgarian, Czech, and Slovak origin, including two homozygotes. Most patients presented with early disease onset, pancreas insufficiency (PI), and early pulmonary involvement, suggesting that this mutation can lead to a severe course of CF. Most R347P alleles in the group studied share a common polymorphic haplotype. In addition, these analyses gave evidence for recurrence of the mutation in two CF patients of German and Czech origin. (C) 1995 Wiley-Liss, Inc.
引用
下载
收藏
页码:219 / 225
页数:7
相关论文
共 50 条
  • [1] PATHOPHYSIOLOGY OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS
    MARSHALL, BC
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 15 (05) : 364 - 374
  • [2] TREATMENT OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS
    MISCHLER, EH
    SEMINARS IN RESPIRATORY MEDICINE, 1985, 6 (04): : 271 - 284
  • [3] COMPLICATIONS OF CYSTIC-FIBROSIS PULMONARY-DISEASE
    LESTER, LA
    SEMINARS IN RESPIRATORY MEDICINE, 1985, 6 (04): : 285 - 298
  • [4] CLINICAL MANAGEMENT OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS
    FIEL, SB
    LANCET, 1993, 341 (8852): : 1070 - 1074
  • [5] 2 PATIENTS WITH CYSTIC-FIBROSIS, NONSENSE MUTATIONS IN EACH CYSTIC-FIBROSIS GENE, AND MILD PULMONARY-DISEASE
    CUTTING, GR
    KASCH, LM
    ROSENSTEIN, BJ
    TSUI, LC
    KAZAZIAN, HH
    ANTONARAKIS, SE
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (24): : 1685 - 1689
  • [6] A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS
    HIGHSMITH, WE
    BURCH, LH
    ZHOU, ZQ
    OLSEN, JC
    BOAT, TE
    SPOCK, A
    GORVOY, JD
    QUITTELL, L
    FRIEDMAN, KJ
    SILVERMAN, LM
    BOUCHER, RC
    KNOWLES, MR
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15): : 974 - 980
  • [7] TOBRAMYCIN AND TICARCILLIN THERAPY FOR EXACERBATIONS OF PULMONARY-DISEASE IN PATIENTS WITH CYSTIC-FIBROSIS
    PARRY, MF
    NEU, HC
    JOURNAL OF INFECTIOUS DISEASES, 1976, 134 : S194 - S199
  • [8] CONTROVERSIES IN THE MANAGEMENT OF PULMONARY-DISEASE DUE TO CYSTIC-FIBROSIS
    FICK, RB
    STILLWELL, PC
    CHEST, 1989, 95 (06) : 1319 - 1327
  • [9] INVITRO CORRELATES OF PULMONARY-DISEASE ACTIVITY IN CYSTIC-FIBROSIS
    MOSS, RB
    LEWISTON, NJ
    EUROPEAN JOURNAL OF PEDIATRICS, 1981, 137 (01) : 110 - 110
  • [10] DEVELOPMENTAL DELAYS AND PULMONARY-DISEASE SEVERITY IN CYSTIC-FIBROSIS
    MAHANEY, MC
    MCCOY, KS
    HUMAN BIOLOGY, 1986, 58 (03) : 445 - 460